AWM
MDCO

Avior Wealth Management’s Medicines Co MDCO Stock Holding History

Avior Wealth Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,510
Closed -$775K – 910
2019
Q3 		$775K Buy
15,510
+2,670
+21% +$107K 0.14% 150
2019
Q2 		$468K Sell
12,840
-2,410
-16% -$78.7K 0.08% 219
2019
Q1 		$426K Buy
15,250
+8,240
+118% +$194K 0.09% 224
2018
Q4 		$134K Buy
7,010
+1,320
+23% +$30.7K 0.03% 389
2018
Q3 		$170K Sell
5,690
-100
-2% -$3.77K 0.04% 380
2018
Q2 		$212K Buy
5,790
+1,160
+25% +$37.7K 0.05% 316
2018
Q1 		$153K Buy
4,630
+10
+0.2% +$312 0.04% 383
2017
Q4 		$126K Buy
+4,620
New +$142K 0.03% 423

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Avior Wealth Management's MDCO Position: Q4 2019 in Review

Avior Wealth Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 15,510 shares — an estimated $775K sold.

Avior Wealth Management first reported a position in MDCO in Q4 2017 and held it in 8 quarters. The position peaked at $775K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Avior Wealth Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Avior Wealth Management sold 15,510 Medicines Co shares in Q4 2019, an estimated $775K.
  • Avior Wealth Management first reported a position in Medicines Co in Q4 2017 and held it in 8 quarters.
  • Avior Wealth Management's Medicines Co position peaked at $775K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Avior Wealth Management's 13F filing for Q4 2019, filed 11 Feb 2020.